rs373052263

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001365536.1(SCN9A):​c.2205G>C​(p.Lys735Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000958 in 1,587,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K735K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.161

Publications

0 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12454927).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2205G>C p.Lys735Asn missense_variant Exon 14 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2205G>C p.Lys735Asn missense_variant Exon 14 of 27 NM_001365536.1 ENSP00000495601.1
SCN9AENST00000303354.11 linkc.2205G>C p.Lys735Asn missense_variant Exon 14 of 27 5 ENSP00000304748.7
SCN9AENST00000409672.5 linkc.2172G>C p.Lys724Asn missense_variant Exon 14 of 27 5 ENSP00000386306.1
SCN9AENST00000645907.1 linkc.2172G>C p.Lys724Asn missense_variant Exon 14 of 27 ENSP00000495983.1
SCN9AENST00000454569.6 linkc.2172G>C p.Lys724Asn missense_variant Exon 14 of 15 1 ENSP00000413212.2

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152090
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000383
AC:
8
AN:
209070
AF XY:
0.0000446
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000780
Gnomad OTH exome
AF:
0.000187
GnomAD4 exome
AF:
0.000102
AC:
146
AN:
1434980
Hom.:
0
Cov.:
31
AF XY:
0.0000914
AC XY:
65
AN XY:
711144
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33134
American (AMR)
AF:
0.00
AC:
0
AN:
41364
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25550
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38986
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82614
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51860
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.000122
AC:
134
AN:
1096404
Other (OTH)
AF:
0.000202
AC:
12
AN:
59338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
152090
Hom.:
0
Cov.:
32
AF XY:
0.0000539
AC XY:
4
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41402
American (AMR)
AF:
0.00
AC:
0
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.0000582
AC:
7
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Aug 16, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2172G>C (p.K724N) alteration is located in exon 14 (coding exon 13) of the SCN9A gene. This alteration results from a G to C substitution at nucleotide position 2172, causing the lysine (K) at amino acid position 724 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 724 of the SCN9A protein (p.Lys724Asn). This variant is present in population databases (rs373052263, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. ClinVar contains an entry for this variant (Variation ID: 538475). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.069
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.25
.;T;.;.;T;.;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.15
T;.;T;T;T;T;T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.12
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.041
T
MutationAssessor
Benign
1.6
.;L;.;.;L;L;.
PhyloP100
0.16
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.66
N;D;.;.;.;N;.
REVEL
Benign
0.23
Sift
Benign
0.034
D;D;.;.;.;D;.
Sift4G
Benign
0.35
T;T;.;.;.;T;.
Vest4
0.29
MutPred
0.59
Loss of methylation at K724 (P = 0.0032);.;Loss of methylation at K724 (P = 0.0032);Loss of methylation at K724 (P = 0.0032);.;.;Loss of methylation at K724 (P = 0.0032);
MVP
0.70
MPC
0.14
ClinPred
0.059
T
GERP RS
2.8
Varity_R
0.17
gMVP
0.43
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373052263; hg19: chr2-167137005; API